Considerations on safety concerns about citalopram prescribing

Mayo Clin Proc. 2012 Nov;87(11):1042-5. doi: 10.1016/j.mayocp.2012.07.009. Epub 2012 Sep 24.
No abstract available

MeSH terms

  • Antidepressive Agents, Second-Generation / adverse effects*
  • Antidepressive Agents, Second-Generation / therapeutic use
  • Citalopram / adverse effects*
  • Citalopram / therapeutic use
  • Depression / drug therapy*
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug Approval
  • Drug Monitoring
  • Heart Conduction System / drug effects
  • Humans
  • Long QT Syndrome / chemically induced
  • Long QT Syndrome / prevention & control
  • Practice Guidelines as Topic*
  • Practice Patterns, Physicians' / standards*
  • Safety Management / standards*
  • Selective Serotonin Reuptake Inhibitors / adverse effects
  • Selective Serotonin Reuptake Inhibitors / therapeutic use*
  • United States
  • United States Food and Drug Administration

Substances

  • Antidepressive Agents, Second-Generation
  • Serotonin Uptake Inhibitors
  • Citalopram